Sustainability Report

Overview

The report presents ScinoPharm's 2023 sustainability performance across governance, environmental protection, workplace, and social engagement. It highlights consolidated revenue of NT$3.186 billion and total GHG emissions of 21,360.51 tCO2e/year, alongside 218,964 kWh of solar generation. The workforce disclosures report 753 employees and the board disclosures report three female directors, or 18% of the board. Selected indicators were subject to PwC Taiwan limited assurance.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services